A Bayesian approach to joint analysis of multivariate longitudinal data and parametric accelerated failure time

Stat Med. 2014 Feb 20;33(4):580-94. doi: 10.1002/sim.5956. Epub 2013 Sep 6.

Abstract

Impairment caused by Parkinson's disease (PD) is multidimensional (e.g., sensoria, functions, and cognition) and progressive. Its multidimensional nature precludes a single outcome to measure disease progression. Clinical trials of PD use multiple categorical and continuous longitudinal outcomes to assess the treatment effects on overall improvement. A terminal event such as death or dropout can stop the follow-up process. Moreover, the time to the terminal event may be dependent on the multivariate longitudinal measurements. In this article, we consider a joint random-effects model for the correlated outcomes. A multilevel item response theory model is used for the multivariate longitudinal outcomes and a parametric accelerated failure time model is used for the failure time because of the violation of proportional hazard assumption. These two models are linked via random effects. The Bayesian inference via MCMC is implemented in 'BUGS' language. Our proposed method is evaluated by a simulation study and is applied to DATATOP study, a motivating clinical trial to determine if deprenyl slows the progression of PD.

Keywords: Markov chain Monte Carlo; clinical trial; failure time; item response theory; latent variable.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Bayes Theorem*
  • Computer Simulation
  • Disease Progression
  • Drug Therapy, Combination
  • Humans
  • Longitudinal Studies / methods*
  • Markov Chains
  • Models, Statistical*
  • Monte Carlo Method
  • Multivariate Analysis*
  • Parkinson Disease / drug therapy*
  • Randomized Controlled Trials as Topic / methods*
  • Selegiline / therapeutic use
  • Tocopherols / therapeutic use

Substances

  • Selegiline
  • Tocopherols